Nvidia slips, GameStop swings big, markets mixed

🌅 Today's Morning Call

S&P Futures 7,410.25 ▼ -15.00 (-0.20%)	Nasdaq Futures 29,176.50 ▼ -149.75 (-0.51%)	Dow Futures 49,777.00 ▲ +9.00 (+0.02%)
10Y Treasury 4.41% ▲ +0.05%	US Dollar 98.26 ▲ +0.11 (+0.11%)	Bitcoin $80,730 ▼ -$997 (-1.22%)

Good morning! Tuesday, May 12, 2026 is arriving with a mixed bag of pre-market signals, a rejected mega-deal, a blockbuster pharma update, and some serious chip drama courtesy of Jensen Huang. Futures are telling two different stories this morning, with the Nasdaq leading losses while the Dow holds its ground. Here is your morning rundown.

👀 What to Watch Today

Traders will want to keep a close eye on any follow-through commentary from Nvidia (NVDA) after the stock pulled back following reports that CEO Jensen Huang was excluded from President Trump's China trip. The chip giant has been riding high, but any signal that its ability to sell into China is getting more complicated could keep pressure on the broader tech sector today.

On the consumer side, Amazon (AMZN) is officially rolling out its 30-minute delivery service across dozens of U.S. cities, and the market will be watching how this announcement lands with analysts and competitors alike. That kind of logistics flex puts heat on everyone from traditional retailers to last-mile delivery players.

The healthcare space is buzzing with real catalysts this morning. Novo Nordisk (NVO) dropped new clinical data showing higher-dose Wegovy driving up to 28% weight loss in some patients, and Bristol Myers Squibb (BMY) is kicking off a massive $15.2 billion licensing partnership with China's Jiangsu Hengrui. Biotech and pharma positioning into today's open could get interesting fast.

Silver at $309 soon? [ad]

🌏 Overnight Recap

European markets digested a flurry of corporate updates overnight. Bayer (BAYRY) reported a 9% jump in first-quarter operating profit, driven largely by its crop protection division, offering a rare bright spot for the German pharma-and-ag giant that has faced years of legal and operational headwinds. Lufthansa (DLAKF) also made headlines, announcing plans to increase its stake in ITA Airways to 90% for approximately $400 million, a deal that consolidates its position in the competitive European aviation market.

Roche (RHHBY) added another win for its diagnostics business, securing a second CE mark in Europe for its Elecsys blood test for Alzheimer's disease. That regulatory green light signals growing momentum in early detection tools, an area investors have been watching closely as the Alzheimer's treatment landscape heats up.

Stateside, the overnight story that grabbed the most attention was GameStop (GME) swinging for the fences with a $56 billion acquisition offer for eBay (EBAY), only to get turned away. EBay cited financing concerns and pointed to its own ongoing turnaround progress. Meanwhile, Under Armour (UA, UAA) is facing pre-market pressure after reporting a quarterly loss tied to declining North American revenue, even as international markets showed signs of life.

SpaceX IPO… the crypto play nobody sees [ad]

📊 Pre-Market Movers

Under Armour (UA, UAA) is drawing attention in pre-market after reporting a fiscal fourth-quarter loss driven by continued weakness in North American revenue. International growth wasn't enough to offset domestic softness, and the stock could face selling pressure as the session opens. This is one to watch for entry points or confirmation of the trend.

Nvidia (NVDA) is seeing some pre-market softness following headlines that CEO Jensen Huang was not included in the Trump administration's China visit. For a company with significant ambitions in the world's second-largest semiconductor market, any friction around access matters. The stock had recently hit new highs, so profit-taking could compound the news-driven dip.

Novo Nordisk (NVO) and Bristol Myers Squibb (BMY) are both worth flagging on the upside. NVO's stronger-than-expected weight-loss data from higher-dose Wegovy gives bulls fresh ammunition, while BMY's $15.2 billion Hengrui deal signals serious pipeline ambition. Both names could attract buy-side interest before the bell.

Buy this Gold Stock in May 2026 [ad]

🔍 Today's Watchlist

1. NVDA: Watch for analyst reactions to the China access concerns and whether support holds near recent highs
2. NVO: New Wegovy weight-loss data could move the stock and lift the broader GLP-1 sector early
3. GME and EBAY: The rejected $56B bid is one of the wilder headlines of the year and both names could see elevated volume
4. 10-Year Treasury at 4.41%: Rising yields are keeping a lid on growth stocks, worth monitoring for any acceleration
5. AMZN: The 30-minute delivery rollout is a logistics story with competitive implications for the entire retail sector

🎯 The Morning Playbook

The playbook today is really about separating signal from noise in a mixed-futures environment. The Nasdaq is under mild pressure from Nvidia's China overhang and rising Treasury yields, but that doesn't mean the session has to turn negative. Selective positioning in healthcare, particularly around NVO and BMY, looks interesting given the fresh catalysts.

On the macro side, keep the dollar (DXY at 98.26) and the 10-year yield (4.41%) on your screen. Both are ticking higher, which tends to create headwinds for rate-sensitive growth names. If yields push further, expect more rotation from tech into value and dividend plays.

The GameStop and eBay saga is entertaining, but don't let it distract from the real market-moving stories today. Nvidia's China situation and Novo Nordisk's clinical data are the names with actual price-moving potential. Stay focused, size appropriately, and remember that mixed-open mornings like this one often clarify quickly once the first hour of trading shakes out.

Guess which tech stock is about to crash next? [ad]